Abstract:Highlights•Comprehensive collection of experimentally verified human–virus PPIs.•Viral proteins interact with cell cycle and immune-related genes.•Viral proteins are likely to interact with central human proteins in PPI network.•Network analysis reveals associations between viral infections and human diseases.•Potential anti-viral drugs are prioritized based on interactome analysis.The protein-protein interactions (PPIs) between human and viruses play important roles in viral infection and host immune responses. Rapid accumulation of experimentally validated human–virus PPIs provides an unprecedented opportunity to investigate the regulatory pattern of viral infection. However, we are still lack of knowledge about the regulatory patterns of human–virus interactions. We collected 27,293 experimentally validated human–virus PPIs, covering 8 virus families, 140 viral proteins and 6,059 human proteins. Functional enrichment analysis revealed that the viral interacting proteins were likely to be enriched in cell cycle and immune-related pathways. Moreover, we analysed the topological features of the viral interacting proteins and found that they were likely to locate in central regions of human PPI network. Based on network proximity analyses of diseases genes and human–virus interactions in the human interactome, we revealed the associations between complex diseases and viral infections. Network analysis also implicated potential antiviral drugs that were further validated by text mining. Finally, we presented the Human–Virus Protein-Protein Interaction database (HVPPI, http://bio-bigdata.hrbmu.edu.cn/HVPPI), that provides experimentally validated human–virus PPIs as well as seamlessly integrates online functional analysis tools. In summary, comprehensive understanding the regulatory pattern of human–virus interactome will provide novel insights into fundamental infectious mechanism discovery and new antiviral therapy development.

A virus–target host proteins recognition method based on integrated complexes data and seed extension

Learning the Drug Target-Likeness of A Protein

Computer Prediction of Drug Resistance Mutations in Proteins

Virus-Derived Peptides for Clinical Applications

Exploring Viral–Host Protein Interactions as Antiviral Therapies: A Computational Perspective

Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis

Systematic Optimization of Host-Directed Therapeutic Targets and Preclinical Validation of Repositioned Antiviral Drugs

Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challenges

Virus-like Iron-Gold Heterogeneous Nanoparticles for Drug Target Screening

Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2

SARS-CoV-2-host proteome interactions for antiviral drug discovery

Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus–Host Interactome

A comprehensive review on targeting cluster of differentiation: An attractive strategy for inhibiting viruses through host proteins

Human enterovirus 71 protein interaction network prompts antiviral drug repositioning

Computer-Aided Prediction of the Interactions of Viral Proteases with Antiviral Drugs: Antiviral Potential of Broad-Spectrum Drugs

A New Integrated Framework for the Identification of Potential Virus–drug Associations

Current Progress in Antiviral Strategies.

Comprehensive characterization of human–virus protein-protein interactions reveals disease comorbidities and potential antiviral drugs

Cell Fractionation and the Identification of Host Proteins Involved in Plant–Virus Interactions

Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets.

The Domain Landscape of Virus-Host Interactomes.